AAAAAA

   
Results: 1-8 |
Results: 8
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies
Authors: Somlo, G Chow, W Hamasaki, V Leong, L Margolin, K Morgan, R Sniecinski, I Frankel, P Reardon, D Longmate, J Raschko, J Shibata, S O'Donnell, M Smith, E Tetef, M Forman, S Yen, Y Molina, A Doroshow, JH
Citation: G. Somlo et al., Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies, BIOL BLOOD, 7(5), 2001, pp. 284-293
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring
Authors: Openshaw, H Lund, BT Kashyap, A Atkinson, R Sniecinski, I Weiner, LP Forman, S
Citation: H. Openshaw et al., Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring, BIOL BLOOD, 6(5A), 2000, pp. 563-575
Photochemotherapy for GvHD
Authors: Sniecinski, I
Citation: I. Sniecinski, Photochemotherapy for GvHD, INT J ARTIF, 23(1), 2000, pp. 1-10
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy
Authors: Molina, A Krishnan, AY Nademanee, A Zabner, R Sniecinski, I Zaia, J Forman, SJ
Citation: A. Molina et al., High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy, CANCER, 89(3), 2000, pp. 680-689
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
Authors: Krishnan, A Bhatia, S Slovak, ML Arber, DA Niland, JC Nademanee, A Fung, H Bhatia, R Kashyap, A Molina, A O'Donnell, MR Parker, PA Sniecinski, I Snyder, DS Spielberger, R Stein, A Forman, SJ
Citation: A. Krishnan et al., Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors, BLOOD, 95(5), 2000, pp. 1588-1593
Toward standardization of CD34+ cell enumeration: an international study
Authors: Dzik, W Sniecinski, I Fischer, J
Citation: W. Dzik et al., Toward standardization of CD34+ cell enumeration: an international study, TRANSFUSION, 39(8), 1999, pp. 856-863
Frequency of immediate adverse effects associated with therapeutic apheresis
Authors: McLeod, BC Sniecinski, I Ciavarella, D Owen, H Price, TH Randels, MJ Smith, JW
Citation: Bc. Mcleod et al., Frequency of immediate adverse effects associated with therapeutic apheresis, TRANSFUSION, 39(3), 1999, pp. 282-288
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy
Authors: Somlo, G Sniecinski, I ter Veer, A Longmate, J Knutson, G Vuk-Pavlovic, S Bhatia, R Chow, W Leong, L Morgan, R Margolin, K Raschko, J Shibata, S Tetef, M Yen, Y Forman, S Jones, D Ashby, M Fyfe, G Hellmann, S Doroshow, JH
Citation: G. Somlo et al., Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy, BLOOD, 93(9), 1999, pp. 2798-2806
Risultati: 1-8 |